Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40cc

Jong Lee, Seok Ho Kang, Je-Jong Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: This study was conducted to evaluate the quality of life and efficacy of treatment after 80 watts high power potassium-titanyl-phosphate laser vaporization for patients with a prostate volume greater than 40cc. We adopted the benign prostatic hyperplasia (BPH) quality of life (QoL)-K1 short form that was developed by the Korean Urological Association in 2001 to more accurately assess the quality of life of patients with BPH. Materials and methods: From July 2005 to March 2006, we performed KTP laser vaporization on a total of 38 patients with symptomatic benign prostatic hyperplasia of the prostate and all their prostate volumes were more than 40cc. All the patients were evaluated preoperatively and then again at 3 and 6 months postoperatively based on the International Prostate Symptom Score (IPSS), the maximum urinary flow rate (Qmax) and the postvoid residual urine (PVR). We conducted a survey of all the patients regarding BPH with using the QoL-K1 short form by means of mail and phone at a mean of 8.7 months (range: 5-12) postoperatively. Results: The mean operation timewas 50.5 minutes (range: 20-120), and the mean duration of admission and catheterization were 2.9±0.4 days and 22.0±10.9 hours, respectively. The mean total score for the BPH QoL-K1 short form improved from 34.5 preoperatively to 22.5 at 6 months postoperatively (p<0.001). There was a significant improvement in the IPSS, Qmax and PVR after the operation, but there were no differences between these parameters at 3 months and 6 months after KTP laser vaporization. There was dysuria in 9 (24%) patients postoperatively and urinary tract infection occurred in 10 (26%) of all the patients. Conclusions: This study showed that KTP laser vaporization was effective in patients with a prostate volume more than 40cc, and the procedure produced improvements in the IPSS, Qmax,PVR and the BPH QoL-K1 short form. Despite the high rate of dysuria and urinary tract infection, the patients treated with KTP laser showed satisfaction about the operation because of the shortened duration of both admission and catheterization.

Original languageEnglish
Pages (from-to)956-964
Number of pages9
JournalKorean Journal of Urology
Volume48
Issue number9
Publication statusPublished - 2007 Sep 1

Fingerprint

Solid-State Lasers
Laser Therapy
Prostate
Quality of Life
Prostatic Hyperplasia
Dysuria
Urine
Urinary Tract Infections
Catheterization
Postal Service

Keywords

  • Benign prostatic hyperplasia
  • Laser vaporization
  • Quality of life

ASJC Scopus subject areas

  • Urology

Cite this

@article{e3e092e4178c4ee686c7fde72ee9046f,
title = "Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40cc",
abstract = "Purpose: This study was conducted to evaluate the quality of life and efficacy of treatment after 80 watts high power potassium-titanyl-phosphate laser vaporization for patients with a prostate volume greater than 40cc. We adopted the benign prostatic hyperplasia (BPH) quality of life (QoL)-K1 short form that was developed by the Korean Urological Association in 2001 to more accurately assess the quality of life of patients with BPH. Materials and methods: From July 2005 to March 2006, we performed KTP laser vaporization on a total of 38 patients with symptomatic benign prostatic hyperplasia of the prostate and all their prostate volumes were more than 40cc. All the patients were evaluated preoperatively and then again at 3 and 6 months postoperatively based on the International Prostate Symptom Score (IPSS), the maximum urinary flow rate (Qmax) and the postvoid residual urine (PVR). We conducted a survey of all the patients regarding BPH with using the QoL-K1 short form by means of mail and phone at a mean of 8.7 months (range: 5-12) postoperatively. Results: The mean operation timewas 50.5 minutes (range: 20-120), and the mean duration of admission and catheterization were 2.9±0.4 days and 22.0±10.9 hours, respectively. The mean total score for the BPH QoL-K1 short form improved from 34.5 preoperatively to 22.5 at 6 months postoperatively (p<0.001). There was a significant improvement in the IPSS, Qmax and PVR after the operation, but there were no differences between these parameters at 3 months and 6 months after KTP laser vaporization. There was dysuria in 9 (24{\%}) patients postoperatively and urinary tract infection occurred in 10 (26{\%}) of all the patients. Conclusions: This study showed that KTP laser vaporization was effective in patients with a prostate volume more than 40cc, and the procedure produced improvements in the IPSS, Qmax,PVR and the BPH QoL-K1 short form. Despite the high rate of dysuria and urinary tract infection, the patients treated with KTP laser showed satisfaction about the operation because of the shortened duration of both admission and catheterization.",
keywords = "Benign prostatic hyperplasia, Laser vaporization, Quality of life",
author = "Jong Lee and Kang, {Seok Ho} and Je-Jong Kim",
year = "2007",
month = "9",
day = "1",
language = "English",
volume = "48",
pages = "956--964",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "9",

}

TY - JOUR

T1 - Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40cc

AU - Lee, Jong

AU - Kang, Seok Ho

AU - Kim, Je-Jong

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Purpose: This study was conducted to evaluate the quality of life and efficacy of treatment after 80 watts high power potassium-titanyl-phosphate laser vaporization for patients with a prostate volume greater than 40cc. We adopted the benign prostatic hyperplasia (BPH) quality of life (QoL)-K1 short form that was developed by the Korean Urological Association in 2001 to more accurately assess the quality of life of patients with BPH. Materials and methods: From July 2005 to March 2006, we performed KTP laser vaporization on a total of 38 patients with symptomatic benign prostatic hyperplasia of the prostate and all their prostate volumes were more than 40cc. All the patients were evaluated preoperatively and then again at 3 and 6 months postoperatively based on the International Prostate Symptom Score (IPSS), the maximum urinary flow rate (Qmax) and the postvoid residual urine (PVR). We conducted a survey of all the patients regarding BPH with using the QoL-K1 short form by means of mail and phone at a mean of 8.7 months (range: 5-12) postoperatively. Results: The mean operation timewas 50.5 minutes (range: 20-120), and the mean duration of admission and catheterization were 2.9±0.4 days and 22.0±10.9 hours, respectively. The mean total score for the BPH QoL-K1 short form improved from 34.5 preoperatively to 22.5 at 6 months postoperatively (p<0.001). There was a significant improvement in the IPSS, Qmax and PVR after the operation, but there were no differences between these parameters at 3 months and 6 months after KTP laser vaporization. There was dysuria in 9 (24%) patients postoperatively and urinary tract infection occurred in 10 (26%) of all the patients. Conclusions: This study showed that KTP laser vaporization was effective in patients with a prostate volume more than 40cc, and the procedure produced improvements in the IPSS, Qmax,PVR and the BPH QoL-K1 short form. Despite the high rate of dysuria and urinary tract infection, the patients treated with KTP laser showed satisfaction about the operation because of the shortened duration of both admission and catheterization.

AB - Purpose: This study was conducted to evaluate the quality of life and efficacy of treatment after 80 watts high power potassium-titanyl-phosphate laser vaporization for patients with a prostate volume greater than 40cc. We adopted the benign prostatic hyperplasia (BPH) quality of life (QoL)-K1 short form that was developed by the Korean Urological Association in 2001 to more accurately assess the quality of life of patients with BPH. Materials and methods: From July 2005 to March 2006, we performed KTP laser vaporization on a total of 38 patients with symptomatic benign prostatic hyperplasia of the prostate and all their prostate volumes were more than 40cc. All the patients were evaluated preoperatively and then again at 3 and 6 months postoperatively based on the International Prostate Symptom Score (IPSS), the maximum urinary flow rate (Qmax) and the postvoid residual urine (PVR). We conducted a survey of all the patients regarding BPH with using the QoL-K1 short form by means of mail and phone at a mean of 8.7 months (range: 5-12) postoperatively. Results: The mean operation timewas 50.5 minutes (range: 20-120), and the mean duration of admission and catheterization were 2.9±0.4 days and 22.0±10.9 hours, respectively. The mean total score for the BPH QoL-K1 short form improved from 34.5 preoperatively to 22.5 at 6 months postoperatively (p<0.001). There was a significant improvement in the IPSS, Qmax and PVR after the operation, but there were no differences between these parameters at 3 months and 6 months after KTP laser vaporization. There was dysuria in 9 (24%) patients postoperatively and urinary tract infection occurred in 10 (26%) of all the patients. Conclusions: This study showed that KTP laser vaporization was effective in patients with a prostate volume more than 40cc, and the procedure produced improvements in the IPSS, Qmax,PVR and the BPH QoL-K1 short form. Despite the high rate of dysuria and urinary tract infection, the patients treated with KTP laser showed satisfaction about the operation because of the shortened duration of both admission and catheterization.

KW - Benign prostatic hyperplasia

KW - Laser vaporization

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=34848855752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848855752&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 956

EP - 964

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 9

ER -